Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Protalix BioTherapeutics (PLX) Other Non Operating Income (2016 - 2025)

Historic Other Non Operating Income for Protalix BioTherapeutics (PLX) over the last 17 years, with Q3 2025 value amounting to $288000.0.

  • Protalix BioTherapeutics' Other Non Operating Income rose 9072.85% to $288000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year decrease of 2941.18%. This contributed to the annual value of $1.3 million for FY2024, which is 2286.22% down from last year.
  • Latest data reveals that Protalix BioTherapeutics reported Other Non Operating Income of $288000.0 as of Q3 2025, which was up 9072.85% from $272000.0 recorded in Q2 2025.
  • Protalix BioTherapeutics' Other Non Operating Income's 5-year high stood at $1.8 million during Q4 2022, with a 5-year trough of -$2000.0 in Q4 2021.
  • In the last 5 years, Protalix BioTherapeutics' Other Non Operating Income had a median value of $288000.0 in 2025 and averaged $395105.3.
  • Per our database at Business Quant, Protalix BioTherapeutics' Other Non Operating Income crashed by 10253.16% in 2021 and then soared by 8850000.0% in 2022.
  • Quarter analysis of 5 years shows Protalix BioTherapeutics' Other Non Operating Income stood at -$2000.0 in 2021, then soared by 88500.0% to $1.8 million in 2022, then crashed by 79.58% to $361000.0 in 2023, then crashed by 68.7% to $113000.0 in 2024, then skyrocketed by 154.87% to $288000.0 in 2025.
  • Its Other Non Operating Income was $288000.0 in Q3 2025, compared to $272000.0 in Q2 2025 and $419000.0 in Q1 2025.